Display Settings:

Format

Send to:

Choose Destination
    Inflamm Res. 2009 Mar 5. [Epub ahead of print]

    Killer B lymphocytes: the evidence and the potential.

    Source

    Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, 48109-2200, USA, sklundy@umich.edu.

    Abstract

    Immune regulation plays a critical role in controlling potentially dangerous inflammation and maintaining health. The Fas ligand/Fas receptor axis has been studied extensively as a mechanism of killing T cells and other cells during infections, autoimmunity, and cancer. FasL expression has been primarily attributed to activated T cells and NK cells. Evidence has emerged that B lymphocytes can express FasL and other death-inducing ligands, and can mediate cell death under many circumstances. Among B cell subsets, the expression of both Fas ligand and IL-10 is highest on the CD5(+) B cell population, suggesting that CD5(+) B cells may have a specialized regulatory function. The relevance of killer B cells to normal immune regulation, disease pathogenesis, and inflammation is discussed.

    PMID:
    19262989
    [PubMed - as supplied by publisher]
    PMCID:
    PMC2892642
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Fig. 1

      Supplemental Content

      Icon for Springer Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk